RSS feed

Publications (original articles or review articles) published in 2024 from OUS - Department of Urology

6 publications found

Cai T, Tamanini I, Odorizzi K, Gallelli L, Lanzafame M, Mazzoli S, Lanzafame P, Massidda O, Palmieri A, Wagenlehner FME, Bjerklund Johansen TE, De Nunzio C (2024)
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer
Prostate Cancer Prostatic Dis (in press)
DOI 10.1038/s41391-024-00824-0, PubMed 38555411

Cai T, Tamanini I, Puglisi M, Bizzotto L, Rizzo M, Liguori G, Gallelli L, Palmieri A, Bjerklund Johansen TE (2024)
Phytotherapy Might Have a Role in Reducing Unnecessary Prostate Biopsies: Results from an Exploratory, Randomized Controlled Trial of Two Different Phytotherapeutic Agents
Clin Pract, 14 (1), 188-197
DOI 10.3390/clinpract14010016, PubMed 38391402

Galtung KF, Lauritzen PM, Sandbæk G, Bay D, Ponzi E, Baco E, Cowan NC, Naas AM, Rud E (2024)
Computed tomography for visible haematuria - a single nephrographic phase is sufficient for detecting renal cell carcinoma
Scand J Urol, 59, 10-18
DOI 10.2340/sju.v59.18467, PubMed 38226799

Gerdtsson A, Negaard HFS, Almås B, Bergdahl AG, Cohn-Cedermark G, Glimelius I, Halvorsen D, Haugnes HS, Hedlund A, Hellström M, Holmberg G, Karlsdóttir Á, Kjellman A, Larsen SM, Thor A, Wahlqvist R, Ståhl O, Tandstad T (2024)
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
BJU Int (in press)
DOI 10.1111/bju.16289, PubMed 38293778

Jacewicz M, Rud E, Lauritzen P, Baco E (2024)
Non-infectious adverse events of transperineal prostate biopsies performed under local anaesthesia
BJU Int (in press)
DOI 10.1111/bju.16383, PubMed 38679416

Löffeler S, Bertilsson H, Müller C, Aas K, Haugnes HS, Aksnessaether B, Pesonen M, Thon K, Tandstad T, Murtola T, Poulsen MH, Nordstrøm T, Vigmostad MN, Ottosson F, Holmsten K, Christiansen O, Slaaen M, Haug ES, Storås AH, Asphaug L, Rannikko A, Brasso K, Scandinavian Prostate Cancer Group (SPCG) and the Norwegian Get-Randomized (GRand) Initiative (2024)
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
BJU Int (in press)
DOI 10.1111/bju.16314, PubMed 38469686